Top 50 Life Science VC Funds & Investors in Middle East (June 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
TRANGELS
VC Fund
|
6 | Turkey, United States, Estonia | Seed, Pre-Seed, Angel | Software, Information Technology, Biotechnology | $24k–$1.4M |
|
Integra Holdings
VC Fund
|
4 | Israel | Seed, Series B, Series F | Biotechnology, Pharmaceutical, Life Science | |
|
Israel Innovation Authority
VC Fund
|
4 | Israel, United States, Mali | Grant, Seed, Pre-Seed | Health Care, Biotechnology, Medical Device | $130k–$6M |
|
Sapir Venture Partners
VC Fund
|
4 | Israel, United States, United Kingdom | Seed, Pre-Seed, Series A | Software, Biotechnology, Machine Learning | $1.3M–$40M |
|
Egypt Ventures
VC Fund
|
3 | Egypt, Ireland, United States | Seed, Pre-Seed, Series A | Software, Information Technology, E-Commerce | $28k–$3M |
|
OrbiMed
VC Fund
|
3 | United States, China, Israel | Series B, Series A, Series C | Biotechnology, Health Care, Medical | $10M–$150M |
|
Pitango VC
VC Fund
|
3 | Israel, United States, China | Series A, Series B, Series C | Software, Health Care, Information Technology | $4M–$100M |
|
aMoon Fund
VC Fund
|
3 | United States, Israel, France | Series B, Series A, Series C | Health Care, Biotechnology, Medical | $5.7M–$93M |
|
Grove Ventures
VC Fund
|
3 | Israel, United States | Seed, Series A, Series B | Artificial Intelligence, Software, Machine Learning | $3.5M–$74M |
|
Minrav
VC Fund
|
2 | Israel, Malaysia | Series A | Health Care, Hospital, Wellness | $10M–$10M |
|
LoftyInc Capital
VC Fund
|
2 | United States, Nigeria, Egypt | Seed, Pre-Seed, Series A | Financial Services, FinTech, Software | $100k–$37M |
|
Acasia Group
VC Fund
|
2 | Egypt, United States, Lebanon | Seed, Angel, Pre-Seed | E-Commerce, Mobile, Software | $175k–$2.6M |
|
Genesis Park
VC Fund
|
2 | United States, Israel | Private Equity, Debt Financing | Health Care, Construction, Manufacturing | $2.5M–$200M |
|
Takeda Ventures
VC Fund
|
2 | United States, United Kingdom, Israel | Series A, Series B | Biotechnology, Health Care, Therapeutics | $10M–$130M |
|
Oryx Fund
VC Fund
|
2 | United Arab Emirates, Saudi Arabia, Oman | Seed, Pre-Seed, Series A | Software, SaaS, FinTech | $500k–$13M |
|
fresh.fund
VC Fund
|
2 | Israel, United States, Norway | Seed, Pre-Seed, Series A | Health Care, Artificial Intelligence, Software | $120k–$21M |
|
Grok Ventures
VC Fund
|
2 | Australia, United States, Singapore | Series A, Seed, Series B | Renewable Energy, Software, Biotechnology | $808k–$150M |
|
Arancia International
VC Fund
|
2 | Israel, United States, Malaysia | Series A, Series B | Health Care, Biotechnology, Life Science | $7.5M–$17M |
|
Pontifax
VC Fund
|
2 | United States, Israel, France | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | $6.3M–$110M |
|
FutuRx
VC Fund
|
2 | Israel | Seed | Biotechnology, Life Science, Biopharma | |
|
Cancer Focus Fund
VC Fund
|
2 | Israel, United States, Germany | Series A, Seed | Biotechnology, Medical, Health Care | $5.4M–$28M |
|
Johnson & Johnson Robotics and Digital Solutions
VC Fund
|
2 | United States, Israel, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $300k–$100M |
|
Neo Ventures
VC Fund
|
2 | Israel, United States, United Kingdom | Seed, Series A | SaaS, Software, Aerospace | $500k–$24M |
|
PeakBridge
VC Fund
|
2 | Israel, United States, United Kingdom | Series A, Seed, Series B | Food and Beverage, Health Care, Food Processing | $768k–$50M |
|
First Star Ventures
VC Fund
|
2 | United States, Canada, Israel | Seed, Pre-Seed, Series A | Software, Artificial Intelligence, Biotechnology | $575k–$15M |
|
SOSV
VC Fund
|
2 | United States, India, United Kingdom | Seed, Convertible Note, Pre-Seed | Biotechnology, Health Care, Software | |
|
OTV
VC Fund
|
1 | United States, Israel, Ghana | Series A, Series B, Seed | Health Care, Medical, Artificial Intelligence | |
|
RMGP Biopharma Investment Fund
VC Fund
|
1 | Israel | Seed, Series B | Biotechnology, Biopharma, Health Care | |
|
Sectoral Asset Management
VC Fund
|
1 | United States, United Kingdom, France | Series B, Series C, Post-IPO Equity | Biotechnology, Health Care, Medical | |
|
HBL Hadasit Bio Holdings
VC Fund
|
1 | Israel | Series A, Series B | Biotechnology, Medical, Health Care | |
|
Arkin Holdings
VC Fund
|
1 | Israel, United States, Switzerland | Series A, Series B | Biotechnology, Health Care, Therapeutics | |
|
Ibtikar Fund
VC Fund
|
1 | Palestinian Territory, United States, Jordan | Seed, Pre-Seed | Artificial Intelligence, E-Commerce, Information Technology | |
|
Arba Finance Ltd.
VC Fund
|
1 | Israel | Series A | AgTech, Medical, Cannabis | |
|
CVentures
VC Fund
|
1 | Turkey | Seed | Delivery, Robotics, Autonomous Vehicles | |
|
Talisman Capital Partners
VC Fund
|
1 | United States, Israel, Hong Kong | Series A, Seed, Series B | Information Services, Pet, News | |
|
Clal Biotechnology Industries
VC Fund
|
1 | Israel, United States | Series A, Series B | Biotechnology, Health Care, Medical | |
|
TPY Capital
VC Fund
|
1 | Israel, United States, France | Seed, Series A, Series B | Software, Artificial Intelligence, Big Data | |
|
e& capital
VC Fund
|
1 | United Arab Emirates, India, United States | Series A, Series B, Series C | Video, Information Technology, Social Media | |
|
Pfizer
VC Fund
|
1 | United States, Israel, France | Post-IPO Equity, Series A, Seed | Biotechnology, Health Care, Pharmaceutical | |
|
Terra Venture Partners
VC Fund
|
1 | Israel, United States | Seed, Series A, Series B | Artificial Intelligence, Machine Learning, Software | |
|
Office of the Chief Scientist
VC Fund
|
1 | Israel | Seed | Health Care, Biotechnology, Hardware | |
|
NextLeap Ventures
VC Fund
|
1 | Israel, United States | Seed, Series A | Software, Machine Learning, Health Care | |
|
ALIVE Israel HealthTech Fund
VC Fund
|
1 | Israel, United States | Series A, Series B | Health Care, Medical, Biotechnology | |
|
Trendlines Group
VC Fund
|
1 | Israel, Singapore, United Kingdom | Seed, Series A | Health Care, Biotechnology, Medical Device | |
|
Annex Investments
VC Fund
|
1 | United Arab Emirates, Saudi Arabia, United States | Seed, Pre-Seed | Information Technology, Software, Artificial Intelligence | |
|
Sente Ventures
VC Fund
|
1 | United States, Turkey, Israel | Pre-Seed, Convertible Note, Seed | Artificial Intelligence, Machine Learning, Software | |
|
Milk and Honey Investments
VC Fund
|
1 | Israel | Series A | Life Science, Organic Food, Biotechnology | |
|
Khosla Ventures
VC Fund
|
1 | United States, India, United Kingdom | Series A, Series B, Seed | Software, Artificial Intelligence, Health Care | |
|
GoodPaper Ventures
VC Fund
|
1 | Series A | Legal, Legal Tech, E-Signature | ||
|
Knuru Capital
VC Fund
|
1 | United Arab Emirates, Spain, Kenya | Series A, Series C | E-Commerce, Information Technology, Financial Services | |
| Access all 50 VC funds in Middle East Life Science startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Early Stage Investment Fund and Network
Show more...Investment focus
- Industry: Software, Information Technology, Biotechnology
- Stage:Seed, Pre-Seed, Angel
- Geography: Turkey, United States, Estonia
Investor stats
- Total investments: 59
- Round size: Seed $52k–$1.4M; Angel $24k–$500k; Pre-Seed $29k–$400k
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- PackUpp — PackUpp is a new generation on-demand “Fast Delivery” technology company and we provide E-Commerce delivery solutions. We serve “Next-Day”, "Same-Day" and "3 Hours Express" deliveries to e-commerce companies. In addition to it, we form “Private Dedicated Field Delivery Teams” to companies as a special delivery team of brand. Wedigitalize all the delivery process by our unique software and technology.Focus on the job which you are best at! Rest, all your packages will be delivered by PackUpp, Fast Delivery Expert.
- Salty Enerji — Salty Enerji is a manufacturing company that designs energy storage infrastructure to enhance renewable power efficiency and distribution.
- Weddingbouquet.com — DüğünBuketi is a web and special event organization portal that brings wedding firms together to get price quotes. It was founded in 2017 and is based in Izmir, Turkey.
Our expert team is the first to examine and evaluate the Hebrew University's biomedical breakthroughs. We then capitalize decades of experience - transforming the inventions into pioneering companies. Our golden eggs Ayana Pharma A late stage company with
Show more...Investment focus
- Industry: Biotechnology, Pharmaceutical, Life Science
- Stage:Seed, Series B, Series F
- Geography: Israel
Investor stats
- Total investments: 8
- Lead/follow: 75% lead, 25% follow
Portfolio highlights
- BacoCure — BacoCure is developing a novel bacterial product for local therapy of non-muscle invasive bladder cancer (NMIBC) patients.
- Splisense — Transformative RNA Based Treatments -Antisense Oligonucleotides- Targeting the Root Cause of Pulmonary Diseases Our innovative RNA based therapies, based on Antisense Oligonucleotides (ASOs), restore and modify protein functionality, addressing untreatable pulmonary diseases.
- Rebiotic Rx — Develops nanotechnology-based antibiotics with the focus on resistant bacteria
The Israel Innovation Agency, the Innovation Authority, was established in 1965 as the Office of the Chief Scientist of the Ministry of Industry and Trade and was designed as a body that supports R & D conducted in the framework of government research institutes. Industrial development in order to increase industrial exports of high-techproducts. The Chief Scientist focused on reducing the risk by participating in financing the project, which the private companies chose and led.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Grant, Seed, Pre-Seed
- Geography: Israel, United States, Mali
Investor stats
- Total investments: 152
- Round size: Seed $590k–$6M; Grant $130k–$4M; Pre-Seed $150k–$2.5M
- Lead/follow: 48% lead, 52% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Q-Factor —
- Sub-Q Bionics — Sub-Q Bionics is a medtech company, that aids the management of chronic pain and debilitating symptoms of lymphedema specially for women.
- Scala Biodesign — At Scala Biodesign, we provide our partners a unique one-shot computational protein design solutions to dramatically increase the value and accelerate the development of proteins into commercial products.
Early Stage VC
Show more...Investment focus
- Industry: Software, Biotechnology, Machine Learning
- Stage:Seed, Pre-Seed, Series A
- Geography: Israel, United States, United Kingdom
Investor stats
- Total investments: 20
- Round size: Seed $1.3M–$5M; Series A $10M–$40M
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- Enzymit — Enzymit's platform technology can build molecular machines that enable never before seen chemistry aiming to solve humanity's greatest challenges
- Lidwave — Lidwave’s deep-tech solution revolutionizes 3D sensing and the verticals relying on it by examining the biggest challenge in LiDAR technology from a new perspective, free of bandwidth limitations.
- DeepCure — DeepCure is a Boston-based therapeutics company that harnesses advanced AI, physics-based tools and automation to discover novel small molecules for challenging targets. DeepCure currently has a lead asset in IND-enabling studies and other programs focused on drugging intractable targets that have t
Egypt Ventures is an investment firm that empowers the entrepreneurial ecosystem by investing in accelerators. The firm was founded in 2017 and is based in Columbia.
Show more...Investment focus
- Industry: Software, Information Technology, E-Commerce
- Stage:Seed, Pre-Seed, Series A
- Geography: Egypt, Ireland, United States
Investor stats
- Total investments: 24
- Round size: Seed $100k–$3M; Pre-Seed $28k–$2M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- Flend — Egypt’s first tech enabled, data driven financing solutions platform dedicated to small businesses.
- D OCC Hub — Smart Incident Management Solutions
- InfiniLink — Empowering Hyperscale Datacenters Building Energy-Efficient Ultra-High-Speed Connectivity Solutions
Leading Global Healthcare Platform with Deep Proprietary Resources and Global Industry Coverage.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A, Series C
- Geography: United States, China, Israel
Investor stats
- Total investments: 589
- Round size: Series A $10M–$116M; Series B $24M–$150M; Series C $15M–$143M
- Lead/follow: 35% lead, 65% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- Sonendo — Sonendo developing innovative technologies to transform dentistry by Saving Teeth Through Sound Science®. The GentleWave® System shows significant improvements in clinical efficacy and practice efficiency when compared to standard root canal treatment.1,2, 3 Sonendo is the parent company of TDO® Software, the developer of the most widely usedendodontic practice management software in the world, designed to simplify practice workflow. TDO software seamlessly integrates practice management, imaging, social media, referral reporting, CBCT imaging, and offers built-in communication with the GentleWave System.
- Crown Bioscience — Crown Bioscience is an expert preclinical contract research organization providing oncology services and preclinical cancer models for drug development. Crown Biocience brings clarity to drug discovery worldwide, helping companies solve today's most pressing problems in immuno-oncology, oncology, cardiovascular, and metabolic diseases.
- Aspen Neuroscience — personalized cell therapy Starts with you Learn More about our technology
Pitango VC is a venture capital firm focused on health-tech (Pitango Health-tech) and growth (Pitango Growth) investments in startups around the world in domains such as vertical SaaS, digital health, deep tech, fintech and insurance technology, devops, generative AI, Web3, and food tech.With two offices in Israel, Pitango currently managesseveral venture funds totaling over $2.8 billion in committed capital. It has invested in more than 250 companies.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Series A, Series B, Series C
- Geography: Israel, United States, China
Investor stats
- Total investments: 280
- Round size: Series A $4M–$50M; Series B $7.5M–$44M; Series C $8.2M–$100M
- Lead/follow: 35% lead, 65% follow
- Last fund: Likely still investing — raised $175M in 2023
Portfolio highlights
- Nas.com — Nas.io helps anyone go from idea to revenue in 1 minute with AI. Create digital products, build engaged communities, and automate marketing—all in one intuitive platform. Nas.io puts community first. Challenges, events, social feed, and memberships drive revenue growth for your business. Join 200k+ entrepreneurs and build your dream digitalbusiness with AI in 1 minute, no technical skills required.
- Nexite — Nexite develops a platform that provides item tracking, inventory transparency and business intelligence from manufacturing to the customer's home. Its miniature NanoBT batteryless tag can be read by any smartphone, costs a fraction of the cost of similar tags, and is small enough to embed into the item. The company was founded in 2017 andis headquartered in Tel Aviv, Israel.
- Sayata — Sayata delivers rapid growth to brokers and carriers that place commercial risk.The Sayata platform streamlines the quote-bind-issue process allowing insurance professionals to seamlessly place commercial risk in a fraction of the time.Sayata provides an end-to-end technological solution along with educational tools, giving our partners theability to grow their book quickly and efficiently.To date, over 1,000 users across 75 brokerages and carriers partner with Sayata to grow their commercial book.
aMoon is a leading healthtech & life sciences venture fund founded by Marius Nacht and Dr. Yair Schindel. Their team is passionate about building successful businesses and helping biopharma, digital health and medical technology companies realize their potential. They partner with management teams who use technology and cutting-edge science toaccelerate cures for the world’s most life-threatening conditions and those providing solutions for global healthcare’s biggest cost drivers.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series B, Series A, Series C
- Geography: United States, Israel, France
Investor stats
- Total investments: 76
- Round size: Series A $5.7M–$83M; Series B $22M–$93M; Series C $30M–$82M
- Lead/follow: 50% lead, 50% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Adcytherix — Adcytherix is a biopharmaceutical company focused on the development of novel antibody drug conjugates (ADC) to treat high unmet need diseases such as cancer.
- Lin Health — Online chronic pain recovery program designed to get you back to the life you want to live. One-on-one coaching. Real pain reduction results.
- KAHR medical — KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment optionsfor cancer and autoimmune disorders.
Grove Ventures is a leading early-stage venture capital fund in Israel. It partners early with exceptional Israeli founders who believe th...
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Machine Learning
- Stage:Seed, Series A, Series B
- Geography: Israel, United States
Investor stats
- Total investments: 70
- Round size: Seed $3.5M–$20M; Series A $8M–$50M; Series B $20M–$74M
- Lead/follow: 41% lead, 59% follow
- Last fund: Likely still investing — raised $185M in 2022
Portfolio highlights
- Niv-AI — Niv-AI develops an AI platform that optimizes power usage in AI data centers by capturing real-time electricity consumption data and dynamically balancing workloads. It addresses bottlenecks where synchronized GPUs create sharp power spikes, unlocking up to 30% of stranded capacity without new hardware.
- NoTraffic — NoTraffic has developed the first AI-powered traffic signal platform that connects road...
- Scala Biodesign — At Scala Biodesign, we provide our partners a unique one-shot computational protein design solutions to dramatically increase the value and accelerate the development of proteins into commercial products.
Minrav provides engineering and construction services.
Show more...Investment focus
- Industry: Health Care, Hospital, Wellness
- Stage:Series A
- Geography: Israel, Malaysia
Investor stats
- Total investments: 4
- Round size: Series A $10M–$10M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- iwi Life — Algae is the ultimate source of Omega-3s. Research has proven that Omega-3s support cardiovascular health, a balanced mood, and healthy brain development.
- Qualitas Health — Qualitas Health Group aims to serve patients through a network of 500 clinics by 2022 with quality healthcare services across the Asia Pacific.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!LoftyInc Capital Management empowers Afropreneurs to build a prosperous and equitable future in Africa. We deliver value to both founders and investors.........
Show more...Investment focus
- Industry: Financial Services, FinTech, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, Nigeria, Egypt
Investor stats
- Total investments: 147
- Round size: Seed $100k–$5M; Pre-Seed $100k–$2.4M; Series A $250k–$37M
- Lead/follow: 14% lead, 86% follow
- Last fund: Likely still investing — raised $14M in 2021
Portfolio highlights
- Aku — Aku is a financial technology to drive financial inclusion on one mobile device. They provide payments and bring financial services to the doorstep. They support the new business owner in need of the right tools. They offer low-cost, accessible financial services that serve their customers. They radically democratized access to banking and digitalpayment channels.
- AlumUnite — AlumUnite is a purpose-built platform to connect all educated Africans to develop Africa's human capital through alumni groups. We crowd-resource education.
- Reliance Health — Reliance Health Global. Improve the lives of your staff with innovative company healthcare benefits fit for any business. You can rely on us.
Cairo Angels is an angel investment network that invests in and supports early-stage startups it convenes regular investment meetings to review pre-selected potential investees.
Show more...Investment focus
- Industry: E-Commerce, Mobile, Software
- Stage:Seed, Angel, Pre-Seed
- Geography: Egypt, United States, Lebanon
Investor stats
- Total investments: 31
- Round size: Seed $175k–$2.6M; Angel $200k–$300k
- Lead/follow: 42% lead, 58% follow
Portfolio highlights
- Bosta — Bosta provides an on-demand courier app with a B2C focus, allowing users to send parcels to their customers. The platform connects its users to couriers and allows them to monitor the status of the delivery of the package. Bosta was founded in 2017 and is headquartered in Cairo, Al Qahirah, Egypt.
- Nawah Scientific — Nawah is MENA & Africa's first Cloud Lab providing R&D services to the region's scientific sectors.
- Kashat — The region's first nano financial service provider, offering small productive loans, and serving as the entry point to financial inclusion for the un- and underbanked population in Egypt.
Genesis Park is a Houston-based private equity firm focusing on buyouts, partnering strategies with public corporations, and growth financing. We bring capital, commercial execution capabilities and a depth of experience in mergers and acquisitions.We are opportunistic within market sectors where we have depth and exposure. Those sectors includetelecommunications, energy technology and media. Energy technology is a rapidly expanding category, and our Houston base allows us to marry traditional and alternative techniques in upstream and downstream environments. Founded in 2000, Genesis Park has used discipline and patience to build value for our investors, regardless of prevailing market conditions. We are consistently active in our portfolio companies, listening, learning and adding value by working alongside management. While our preference is to partner with an existing management team, we commonly source additional talent to optimize the existing opportunity.
Show more...Investment focus
- Industry: Health Care, Construction, Manufacturing
- Stage:Private Equity, Debt Financing
- Geography: United States, Israel
Investor stats
- Total investments: 22
- Round size: Debt Financing $5.5M–$65M; Private Equity $2.5M–$200M
- Lead/follow: 59% lead, 41% follow
- Last fund: Likely still investing — raised $275M in 2021
Portfolio highlights
- T&R Recovery Group — T&R Recovery Group offers premier residential therapy for trauma and addiction.
- Chemistry Agency — Chemistry Communications offers social media, media planning/buying, interactive trade show marketing, online marketing, Website design and development, mobile marketing, and package design services.
- GLASS BOX TECHNOLOGY INC — Glass Box Technology Inc offers customizable network, storage, security, and server solutions designed to meet the needs of the industries.
Takeda Ventures, Inc. (TVI) is the corporate investment arm of Takeda Pharmaceutical Company Limited (TPC). TVI was founded in 2001 and invests in current and future areas of interest for TPC. They are based alongside Takeda’s R&D sites in Cambridge, MA, and San Diego, CA. As a strategic investor, TVI aims to provide support and guidance toentrepreneurs and early-stage companies driving concepts through clinical proof of concept. They also strive to forge active, collaborative interactions that result in synergies with Takeda's considerable R&D resources. Their goal is to build a portfolio of strategic investments, with an immediate emphasis on oncology, gastroenterology, neuroscience, and rare diseases.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B
- Geography: United States, United Kingdom, Israel
Investor stats
- Total investments: 104
- Round size: Series A $10M–$58M; Series B $20M–$130M
- Lead/follow: 18% lead, 82% follow
Portfolio highlights
- StrideBio — StrideBio is a gene therapy company focused on developing genetic medicines with curative potential for patients with devastating conditions. It leverages its proprietary structure-inspired adeno-associated virus (AAV) vector engineering platform to create unique and differentiated vectors that improve upon naturally occurring AAV serotypes toovercome current limitations of first-generation gene therapies. The company was founded in 2015 and is headquartered in Durham, North Carolina.
- Xilio Therapeutics — WhatsApp Group Invite
- Accipiter Biosciences — Accipiter Biosciences is a biotechnology company.
Oryx Fund is a MENA-focused Investment fund from Hambro Perks. Investing in game-changing early-stage technology companies at late Seed and Series A, led by outstanding entrepreneurs in sectors we have deep expertise such as Fintech, Healthtech, Enterprise tech, Logistics tech, and Edtech.
Show more...Investment focus
- Industry: Software, SaaS, FinTech
- Stage:Seed, Pre-Seed, Series A
- Geography: United Arab Emirates, Saudi Arabia, Oman
Investor stats
- Total investments: 30
- Round size: Seed $500k–$6.5M; Pre-Seed $1M–$2.2M; Series A $5M–$13M
- Lead/follow: 47% lead, 53% follow
Portfolio highlights
- Holo — Find your dream home with Holo, the digital home-buying platform in the UAE. Get expert help, compare mortgages, and simplify your journey to ownership!
- Growdash — Stop chasing data, start driving growth. Meet Aisha, the AI Delivery Manager that actively monitors, optimizes, and grows your delivery business across all third-party platforms.
- Alma Health — Alma Health is a digitally-native chronic illness management platform serving an addressable market of 20m patients in GCC. Through its cloud pharmacy and virtual doctor consultations, Alma Health is translating patient behavior and insights into personalized services and products like digital treatments and at home monitoring systems. Alma Healthis based in Hub71-Abu Dhabi.
fresh.fund is an Israeli pre-seed venture capital fund investing in early-stage startups across segments and verticals.We're built to partner with early-stage founders from day one, often as the company's first institutional investors. Our model is refreshingly simple: up to $300,000 in pre-seed funding within <4 weeks and follow-oncapital as necessary.Check out our portfolio here >> https://www.fresh.fund/portfolio. It's never too early to have a conversation about your startup.
Show more...Investment focus
- Industry: Health Care, Artificial Intelligence, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: Israel, United States, Norway
Investor stats
- Total investments: 41
- Round size: Seed $3M–$12M; Pre-Seed $120k–$6M; Series A $11M–$21M
- Lead/follow: 12% lead, 88% follow
Portfolio highlights
- Wisio — Wisio lets social media creators and experts answer questions and requests from followers via paid interactions. The company’s platform empowers followers to gain exclusive access via personalized videos to their favorite creators. Wisio's flexible and easy-to-use platform is packed with features to help creators build deeper communitieswhile monetizing the creator - follower relationship. Thousands of them are already using it to help build their online reputation and business.Wisio's vision is to make everyone reachable.
- Clearitty — Clearitty - The Ultimate Sales Accelerator by Turning Deal Insights into Revenue We provide the tools and insights for sales executives to close deals faster and outperform competitors, empowering you to drive growth and success. It’s free to start — no trial, no contract, no risk.Clearitty was born out of a shared frustration experienced bysales executives and entrepreneurs alike – the lack of critical insights about new buyers. These invaluable insights are often held by those who have successfully navigated the sales process with these coveted clients.Recognizing the gap, in 2022 we created Clearitty, dedicated to developing an intelligence tool that helps sales executives shorten sales cycles and close deals more efficiently.Our goal is to build the world’s largest database of buyer insights, empowering sales executives with the knowledge they need to succeed.
- Sherloq — Ask your SQL anything. Built on your context, directly on your editor.
Backing a better tomorrow
Show more...Investment focus
- Industry: Renewable Energy, Software, Biotechnology
- Stage:Series A, Seed, Series B
- Geography: Australia, United States, Singapore
Investor stats
- Total investments: 66
- Round size: Seed $808k–$10M; Series A $3.3M–$63M; Series B $12M–$150M
- Lead/follow: 24% lead, 76% follow
Portfolio highlights
- Spriggy — Spriggy is a mobile app with a linked prepaid card that helps kids learn the concept of digital money.
- Airwallex — Established in Melbourne in 2015, Airwallex is a global payments fintech that enables businesses to operate anywhere, anytime.In today’s fast-changing digital era, Airwallex's purpose is to empower businesses of all sizes to grow without borders, and by doing so, contribute to the global economy. With technology at its core, Airwallex builta proprietary global financial infrastructure platform to help businesses transact, collect and pay in any foreign currency across 130+ countries and 50+ currencies, without the constraints of the traditional global financial system.
- August Robotics — August Robotics creates robots to automate "dirty, dangerous and dull" workflows across the B2B economy. The company's first robot, Lionel, automates the dull and labour intensive task of floor-marking for the global exhibition industry. Lionel has been used as a critical part of the trade show setup process by the world'slargest exhibition companies in Europe and USA. August Robotics' second robot, Diego, automates the dirty and dangerous task of disinfecting high-traffic public areas, such as hotels, offices and aged care centers, optimizing hygiene and reducing the risks of infection. The company is also working on a number of other robots, each leveraging August Robotics' industry leading proprietary mobile robotics platform, which enables August Robotics to generate new robots for new cases far more quickly and cheaply than other robotics companies. The physical world is ripe for disruption by robots, and August Robotics is leading the charge to do this in the B2B segment
Arancia International Inc is a part of Arancia Group in Mexico. We are long term investors in food, nutrition and biotechnology companies.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Life Science
- Stage:Series A, Series B
- Geography: Israel, United States, Malaysia
Investor stats
- Total investments: 9
- Round size: Series A $10M–$17M; Series B $7.5M–$11M
- Lead/follow: 22% lead, 78% follow
Portfolio highlights
- NextFerm — NextFerm is a science oriented industrial company, representing a new era in fermentation and fermentation-derived nutrients for supplements, food, infant nutrition and animal feed.The world is striving for better nutrition. Nutrition which is less artificial and more natural, sustainable and cost effective - with a much higher nutritional value.At Nextferm, they aim to use their capabilities to lead this new and exciting world of better nutrition.
- iwi Life — Algae is the ultimate source of Omega-3s. Research has proven that Omega-3s support cardiovascular health, a balanced mood, and healthy brain development.
- The Mediterranean Food Lab — The Mediterranean Food Lab merge traditional fermentation and cutting-edge science, to produce natural plant-based flavor-bases for a wide range of meat replacement needs.
Pontifax is a healthcare-dedicated venture capital firm.The fund focuses on innovative bio-pharma opportunities.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: United States, Israel, France
Investor stats
- Total investments: 111
- Round size: Series A $6.3M–$110M; Series B $20M–$100M; Series C $12M–$104M
- Lead/follow: 24% lead, 76% follow
- Last fund: May invest from a new fund soon — raised $14M in 2020
Portfolio highlights
- Abcuro — Precision Targeting of Highly Cytotoxic T Cells in Autoimmune Disease.
- ADCendo — ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.
- Applied Immune Technologies — Applied Immune Technologies Ltd. engages in development of therapeutic molecules for cancer, viral, and autoimmune diseases. The company develops T-Cell Receptor-Like (TCRL) antibodies that are targeted to intracellular-derived peptides for various therapeutic and diagnostic applications. Its TCRL antibodies also have diagnostic applications inpathology; and vaccine design, validation, and monitoring, as well as in the analysis of antigen presentation in disease. The company was formerly known as BioMimic Pharma. The company was founded in 2006 and is based in Haifa, Israel.
FutuRx is the Israeli biotechnology accelerator that was established in 2014 by OrbiMed Israel Partners, Johnson & Johnson Innovation and Johnson & Johnson Development Corporation (JJDC) and Takeda Ventures Inc. following winning the tender of the Office of the Chief Scientist (OCS), Ministry of Economy, in Israel.The incubator willadvance new biotechnology products by identifying and nurturing early-stage life science innovation.FutuRx is located in the Weizmann Science Park in Ness Ziona (near the Weizmann Institute), Israel.
Show more...Investment focus
- Industry: Biotechnology, Life Science, Biopharma
- Stage:Seed
- Geography: Israel
Investor stats
- Total investments: 3
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Ramino Bio — Ramino Bio is a private biotech company that develops an oral drug to treat metabolic diseases.Ramino has received funding totaling about $3.3 million since its beginning from the FutuRx biotech incubator, which is supported by the Israeli Innovation Authority, Takeda, J&J, OrbiMed, and RMPG. By speeding up their disintegration, our exclusivetechnology lowers the extra BCAA that is floating around.
- Protekt Therapeutics — ProteKt Therapeutics is a drug development company aiming to develop potent and selective oral inhibitors of the kinase PKR for the treatment of neurodegenerative and neuroinflammatory diseases. The company has raised a $4M pre-A round and graduated from the FutuRx accelerator in 2019.
- Bsense Bio Therapeutics — Bsense Bio Therapeutics develops small molecules for the treatment of sensory hyperexcitability related disorders. Bsense pioneers a novel approach targeting multiple hyperexcitability-related mechanisms using a single compound, to achieve greater efficacy and safety.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Cancer Focus Fund is an oncology-focused investment firm advancing breakthrough cancer therapies by partnering with leading scientists, institutions and early-stage companies.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Series A, Seed
- Geography: Israel, United States, Germany
Investor stats
- Total investments: 10
- Round size: Series A $5.4M–$28M
- Lead/follow: 60% lead, 40% follow
- Last fund: May invest from a new fund soon — raised $50M in 2019
Portfolio highlights
- March Biosciences — Transforming Patient Care by Unlocking New Target Spaces march.biosciences is a clinical-stage company in the cell therapy field focused on developing CAR-T cell strategies to address the most challenging hematological cancers Pipeline MB-105 https://march.bio/wp-content/uploads/2023/05/shutterstock_1008023995-HD-30.mp4 Focused on Excellence Target Space Our approach combines biological and engineering insights to enable target-unlock without the risk and complexity of
- Starget Pharma — Starget Pharma develops a new generation of targeted radiopharmaceutical technologies for the treatment of solid tumors. Starget Pharma has a pipeline of novel targeted radiopharmaceutical molecules that act as a vector for selectively transferring radioisotopes to cancer tumor tissues.
- Nectin Therapeutics — NectinTX develops next-generation delivery platforms for immuno-oncology and precision therapeutics. Discover breakthrough protein expression technologies that power safer, more effective treatments.
Healthcare innovation wherever it originates.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: United States, Israel, United Kingdom
Investor stats
- Total investments: 70
- Round size: Series A $5.9M–$63M; Series B $18M–$55M; Series C $300k–$100M
- Lead/follow: 23% lead, 77% follow
Portfolio highlights
- Moon Surgical — Create the OR of the future, one that is sustainable, efficient, and digitalized.
- Artera — Discover the power of Personalized Precision Medicine & AI Cancer Therapy with Artera. Transforming cancer therapy through innovation.
- ONL Therapeutics — ONL Therapeutics develops innovative therapeutics to protect and improve the vision of patients with a range of retinal diseases and conditions.
Neo Ventures is the first open-ended early stage investor, based in Eastern Europe. The founders have backed more than 30 startups and exited 10 successfully. We invest in game-changing businesses, without geographic limitations. We partner with exceptional founder teams to challenge incumbents in markets ripe for change or to create entirely newmarkets. Neo Ventures funds and then supports the founders in business planning, scaling operations, follow-on investments, making the best of each opportunity and dealing with hard situations. Our investment focus is on data analytics, computer vision and remote sensing addressing disruptive opportunities across the high-growth SpaceTech, BioTech and Security verticals.
Show more...Investment focus
- Industry: SaaS, Software, Aerospace
- Stage:Seed, Series A
- Geography: Israel, United States, United Kingdom
Investor stats
- Total investments: 15
- Round size: Seed $500k–$1.7M; Series A $2.3M–$24M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Bulbi — Bulbi is a child development platform designed to help parents discover online and face-to-face educational activities for their children.
- Convex — Convex provides the backend building blocks for your agents. Everything you need to build your full-stack project.
- Cyberwrite — AI-powered cyber insurance intelligence platform that transforms raw data into explainable, defensible financial decisions.
PeakBridge is a highly networked, global impact VC that funds and connects the people, technology and processes that will shape the future of food. We invest in visionary pioneers, from early stage to Series A-B, with scalable, protectable climate and health-focused technologies. At their core: a deep commitment to disrupting our food system whiledriving positive impact. Our team is spread across seven countries and includes pioneers of FoodTech investment and decades of deep Agri-Food operational and financial experience. Together, we create exceptional value for bold FoodTech entrepreneurs and investors. A member of the Edmond de Rothschild Private Equity partnership, PeakBridge is also the only venture capital firm that is an official partner of the world’s largest Agri-Food innovation initiative, EIT Food.
Show more...Investment focus
- Industry: Food and Beverage, Health Care, Food Processing
- Stage:Series A, Seed, Series B
- Geography: Israel, United States, United Kingdom
Investor stats
- Total investments: 49
- Round size: Seed $768k–$11M; Series A $4.9M–$17M; Series B $11M–$50M
- Lead/follow: 43% lead, 57% follow
- Last fund: Likely still investing — raised $106M in 2022
Portfolio highlights
- Mondra — Unlock supply chain intelligence for food system resilience. Discover insights and solutions to build robust and adaptable food supply chains.
- SOUS — One easy-to-use tool to grow traffic, make online sales, seamlessly handle orders and drive retention. Built for food entrepreneurs, built with taste.
- KÄÄPÄ Biotech — Medicinal mushrooms, biotechnology, mycology, forestry, agroforestry, and food production.
Investing with conviction in visionary, technical founders inventing the future.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Biotechnology
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, Canada, Israel
Investor stats
- Total investments: 59
- Round size: Seed $1M–$8.5M; Pre-Seed $575k–$1.8M; Series A $4.2M–$15M
- Lead/follow: 14% lead, 86% follow
Portfolio highlights
- SaolaAI — SaolaAI is the go-to platform for zero-maintenance, maximum-coverage quality, powered by real user behavior insights. With over 30 million user sessions recorded, SaolaAI stands at the forefront of autonomous quality, trusted by hundreds of engineering teams to catch critical issues throughout the application lifecycle, ensuring top-notch productquality with ease.
- Kanary — Established in 2020 by U.S. campaign security and data science experts, Kanary finds, removes, and monitors your information across search engines, data brokers, and social media.
- Blumen Systems — Blumen is an early-stage technology company building software to streamline the regulatory challenges associated with upstream natural resources production in the US. We are focused on producers building and utilizing land-based assets powering the energy transition including carbon sequestration, geothermal, critical minerals, hydrogen, and RNGprojects.
SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Convertible Note, Pre-Seed
- Geography: United States, India, United Kingdom
Investor stats
- Total investments: 1482
- Lead/follow: no public data
Portfolio highlights
- MixRift — MIXRIFT - game developers specialized in Mixed Reality
- unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
- Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
OTV focuses on round A+ startups that aim to make a significant impact on people's lives. Our focus is on entrepreneurs with innovative ideas who are advancing the global state of well-being. Come join the digital health revolution, and be a part of transforming the healthcare industry.
Show more...Investment focus
- Industry: Health Care, Medical, Artificial Intelligence
- Stage:Series A, Series B, Seed
- Geography: United States, Israel, Ghana
Investor stats
- Total investments: 21
- Lead/follow: no public data
Portfolio highlights
- Scopio — Buy & sell images on the largest Solana Photography NFT Marketplace. Find high-quality stock images & hire artists from around the world.
- Scopio Labs — Scopio Labs is a provider of Full Field Morphology dedicated to unlocking the potential of imaging and AI in hematology. Uncovering actionable insights from vast amounts of data readily available in the average blood sample and bone marrow aspirate, Scopio's solutions will aim to showcase thousands of cells at scale in high resolution, toenable new hematology diagnostic methods.
- Stake — Renters earn Cash back for rent. Building operators outperform the market. That's the Stake win-win. Find out how we're building the financial tools for the next generation of rentals.
RMGP Biopharma Investment Fund is an investment Fund
Show more...Investment focus
- Industry: Biotechnology, Biopharma, Health Care
- Stage:Seed, Series B
- Geography: Israel
Investor stats
- Total investments: 3
- Lead/follow: no public data
Portfolio highlights
- Ramino Bio — Ramino Bio is a private biotech company that develops an oral drug to treat metabolic diseases.Ramino has received funding totaling about $3.3 million since its beginning from the FutuRx biotech incubator, which is supported by the Israeli Innovation Authority, Takeda, J&J, OrbiMed, and RMPG. By speeding up their disintegration, our exclusivetechnology lowers the extra BCAA that is floating around.
- Pi Therapeutics — Pi Therapeutics is a discovery-stage biopharmaceutical company aiming to develop a novel cancer drug. The company is financed by a syndicate of Takeda Pharmaceutical Company through its venture group Takeda Ventures Inc., Johnson & Johnson Innovation – JJDC, OrbiMed Israel Partners, Pontifax, and the Israel Innovation Authority, and hasoperated since March 2015 in the FutuRx biotech accelerator in Ness Ziona, Israel. The company’s mission is to develop novel first-in-class drugs directed against the ubiquitin-proteasome system (UPS), mainly for treatment of cancer.
- Protekt Therapeutics — ProteKt Therapeutics is a drug development company aiming to develop potent and selective oral inhibitors of the kinase PKR for the treatment of neurodegenerative and neuroinflammatory diseases. The company has raised a $4M pre-A round and graduated from the FutuRx accelerator in 2019.
Sectoral is specialized in managing equities globally in the healthcare sector. Founded in October 2000, we are SEC-registered as an investment advisor. 100% employee-owned, we have offices in Montreal, Geneva, and Hong Kong.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series C, Post-IPO Equity
- Geography: United States, United Kingdom, France
Investor stats
- Total investments: 48
- Lead/follow: no public data
Portfolio highlights
- CurvaFix — Curvafix is the only intramedullary implant that follows the natural curvature of the pelvis. Continue reading to learn how the Curvafix implant works!
- Boundless Bio — Boundless Bio is a company that develops novel cancer therapeutics intended to understand and treat intraceable cancers. It aims to be the foremost biopharma company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with previously intractable cancers.Boundless Bio was founded in 2018 and isheadquartered in La Jolla, California.
- LENZ Therapeutics — LENZ Therapeutics is a late-stage clinical company developing innovative ophthalmic pharmaceutical products that improve vision.
Hadasit Bio-Holdings Ltd. ("HBL") was founded and floated on the Tel Aviv Stock Exchange (TASE : HDST ) and recently on the OTC (OTCBB : HADSY ) in order to allow public participation in the highly promising field of biotechnology.It serves as a precedent in biotech financing - for the first time, public investment is allowed toparticipate in a holding entity including companies based on IP generated by Israel’s foremost medical research center – Hadassah University Hospital ("HU").In addition to the public holdings (54%) – including major Israeli institutional investors, HBL is held by Hadasit (www.hadasit.co.il) (36%) and Consensus Business Group (http://www.consensusbusiness.com) (10%). The traded stock, as a unique investment vehicle, provides investment exposure to a select cluster of 6 biotech companies - all based on inventions developed and owned by HU.HBL is a publicly traded subsidiary of Hadasit Ltd. – the technology transfer company of the Hadassah University Hospital in Jerusalem, Israel. Hadasit was established for the purpose of promoting and commercializing the intellectual property (IP) and R&D capabilities generated by Hadassah, aimed at finding solutions to problems faced by modern medicine.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Series A, Series B
- Geography: Israel
Investor stats
- Total investments: 9
- Lead/follow: no public data
Portfolio highlights
- ProtAb — ProtAb develops therapeutic agents that modulate cytokine regulation, tipping the balance toward anti-inflammatory signaling pathways in the treatment of autoimmune and inflammatory diseases. Its first product, Prozumab, is a monoclonal antibody with a novel mechanism of action. It is currently in late-stage preclinical development for thetreatment of inflammatory bowel disease or IBD, ulcerative colitis or UC, and rheumatoid arthritis or RA. It operates as a subsidiary of Hadasit Bio-Holdings. HBL is a publicly traded subsidiary of Hadasit, the technology transfer company of the Hadassah University Hospital in Jerusalem in Israel.
- KAHR medical — KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment optionsfor cancer and autoimmune disorders.
- Enlivex Therapeutics — Enlivex is a clinical-stage macrophage reprogramming immunotherapy company that targets diseased macrophages in patients with sepsis. The company develops an autologous and allogeneic drug pipeline for the treatment of autoimmune and inflammatory conditions such as Graft versus Host Disease (GvHD), solid organ transplant rejection, Crohn'sDisease, and other autoimmune and inflammatory disorders.The company's revolutionary approach is to induce immune tolerance by injecting apoptotic cells and facilitating their interaction with dendritic cells activates the body's innate, physiologic mechanism for down-regulating inflammation and autoimmunity.Enlivex is an Israeli-based cell immunotherapy company established in October 2005 by Professor Dror Mevorach, a world-renowned expert on clearance of dying (apoptotic) cells.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Explore Arkin Capital: A leading multi-asset manager driving strategic investments across health, technology, equity, real estate and more
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B
- Geography: Israel, United States, Switzerland
Investor stats
- Total investments: 26
- Lead/follow: no public data
Portfolio highlights
- Phytolon — Phytolon revolutionizes the way food colors are produce, by Leveraging a novel and sustainable technology for production of healthy food colors in high quality at low costs. Phytolon's mission is to exploit scientific advancement promote human health and environmental sustainability
- Honeycomb — Honeycomb (fka Agilius) is the only place where you can buy a condo/apartment building master policy online in less than 3 minutes at a fraction of the cost! Instant, free, no hassle quotes, online everything and up to 40% savings. With all that we're bringing simplicity and transparency to the real estate insurance space for condoassociations (HOAs), building owners, property managers, and developers everywhere. This is what we do. This is all we do.
- Nocion Therapeutics — Nocion Therapeutics is a developer of novel pharmaceuticals intended to treat the conditions arising from neurogenic inflammation. The company is developing "nocions" which are a new kind of therapy that selectively affects actively firing nociceptors, enabling patients to provide targeted, robust and sustained relief for the treatment ofserious conditions including cough, itch, pain and inflammation.
Ibtikar (Innovation, in Arabic) is a disruptive fund that will invest in innovative Palestinian companies. Ibtikar’s investments begin at the seed level through local accelerators, continue in post-acceleration phases and can also include series A investments in its portfolio companies. Through this investment strategy we aim to close a criticalfunding gap between acceleration and VC and other later-stage investors. Our goal is to maximize return for our investors by helping high-potential Palestinian companies answer regional and global needs. We will do this through direct support from our management team and select group of advisors, and will leverage the strong network of our investors and partners for the benefit of each of our portfolio companies.
Show more...Investment focus
- Industry: Artificial Intelligence, E-Commerce, Information Technology
- Stage:Seed, Pre-Seed
- Geography: Palestinian Territory, United States, Jordan
Investor stats
- Total investments: 28
- Lead/follow: no public data
Portfolio highlights
- Nabeeh — Nabeeh is an online platform that allows users to book housekeeping, cleaning services, maintenance, repairs, and renovation services.
- Olivery — Olivery is a comprehensive logistics platform designed to streamline logistics and delivery operations for businesses. It offers smart solutions including efficient route planning, real-time shipment tracking, automated insights, and seamless digital interactions to improve fleet performance and customer service. The platform integrates withleading tools to ensure smooth operations and enhanced customer satisfaction. Olivery focuses on making logistics more efficient, cost-effective, and reliable, empowering companies to save time, reduce expenses, and deliver faster. It also supports various delivery features such as zero-contact delivery via OTP, automatic photo/KYC capture, online payments for cash-on-delivery, and configurable driver information capture.
- DataQueue — Discover essential strategies for AI readiness with DataQueue. Learn how to prepare your business, choose the right AI tools, and develop a strategic AI plan for future success
An investment banking boutique, founded in 1978
Show more...Investment focus
- Industry: AgTech, Medical, Cannabis
- Stage:Series A
- Geography: Israel
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- GemmaCert — GemmaCert is a smart solution for testing cannabis potency, which unlike other solutions, is simple and sleek, for everyday use, requiring no specific skill-set for operation, and whose form gives little indication to the sophistication of the technology working underneath. GemmaCert is a bridge between technology and nature. This design createdthe desired attractive and useful man-machine interface for the best possible user experience along with a well-defined product with aesthetic presence without sacrificing on performance. GemmaCert is making a name for high performance, robustness, ease-of-use and reliability.No cannabis flower is the same, so before anyone consumes cannabis, they should have an understanding exactly what is in it and how it may affect them. From pharmacies in Germany, coffeeshops in Amsterdam, to supply chain stakeholders in North America, GemmaCert brings certainty and confidence to cannabis professionals, as well as consumers and patients worldwide.After over two years in research and development, GemmaCert started delivering first units to customers worldwide, primarily in North America and Europe. Revenues are generated from device sales and monthly subscription fees to our analytical service since GemmaCert units are operated and upgraded via secure cloud-based servers.
CVentures is a corporate venture capital firm of Coşkunöz Holding.
Show more...Investment focus
- Industry: Delivery, Robotics, Autonomous Vehicles
- Stage:Seed
- Geography: Turkey
Investor stats
- Total investments: 3
- Lead/follow: no public data
Portfolio highlights
- Novocycle Technologies — Novocycle Technologies is bringing true circularity to the growing battery market. With its innovative and patented NovoRec Process, Novocycle is recycling Lithium-Ion Batteries without shredding or crushing them, avoiding the production of black mass and directly obtaining reusable active materials in battery grade. With an amazing recoveryefficiency of 96% of the solid materials within the overall battery, Novocycle surpasses all upcoming targets of the EU Battery Regulations for recycling efficiency and recycled content in new batteries. All of this is realized in an economic feasible way, by decentralized micro facilities and a revenue sharing operation model for feedstock providers.
- Saha Robotik — Saha Robotics primarily engages in delivering groceries, cargo and custom items with autonomous cloud connected robots.
- Nanomik Biotechnology — Biochemistry leading change in life sciences. With our proprietary technologies, we develop solutions for Crop Health, Animal Health and Food preservation.
Talisman Capital Partners operates as a private investment company.
Show more...Investment focus
- Industry: Information Services, Pet, News
- Stage:Series A, Seed, Series B
- Geography: United States, Israel, Hong Kong
Investor stats
- Total investments: 7
- Lead/follow: no public data
Portfolio highlights
- Bond Vet — We offer compassionate, thorough, & friendly pet care in a warm, comfortable environment. Walk in or book online.
- Prilenia — Prilenia is a clinical-stage biotech company that develops novel treatments for neurodegenerative and neurodevelopmental disorders. Its lead asset is Pridopidine, a n oral drug candidate with an established safety profile and potential in multiple movement disorders and neurodegenerative diseases affecting adults and children.The company wasfounded in 2018 and is based in Israel, the Netherlands, and Boston.
- qServe Communications — At qServe Communications, it is their unique vision to be a one-stop source for all your maintenance and development needs. They understand the difficulty of locating reliable companies to meet all of your infrastructure requirements. qServe has built an answer to this problem, a national service network of in-house employees to deliver qualitymanagement, installation, erection, inspection and maintenance services to the communications industry.With their full spectrum of project and program management services, they drive your project from start to finish, becoming an integral part of your development team. Many of qServe Communications crews and staff bring many years of valuable experience in the development of communications systems and infrastructures. From Program and Project Management to in-house installation and maintenance services, qServe will work diligently to ensure your project's success.qServe has performed thousands of projects for clients including: AT&T Wireless Services, Alltel Mobile, Nextel, Sprint, Omnipoint, Bell Atlantic Mobile, Teligent, Metricom, American Tower, Crown Castle and SBA Communications Corporation.
Clal Biotechnology Industries is a leading Israeli life sciences investment company traded on the Tel Aviv Stock Exchange (TASE: CBI)
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B
- Geography: Israel, United States
Investor stats
- Total investments: 14
- Lead/follow: no public data
Portfolio highlights
- Sight Diagnostics — Combining AI and breakthrough hardware to bring lab-quality CBC results to the doctor's office.
- Cadent Therapeutics — Cadent Therapeutics is a precision neuroscience company developing novel medicines that tune and modulate brain rhythms to restore cognitive and motor function in patients with serious neurological disease. The company leverages its precision neuroscience approach combining target specificity, patient selection, drug design and optimization, andnovel quantitative endpoints to create first-in-class molecules to treat movement and cognitive disorders.It was founded in 2010 and headquartered in Cambridge, Massachusetts.
- Elicio Therapeutics — Elicio ground-breaking Amphiphile technology is engineering potent vaccines and immunotherapies to defeat an array of aggressive cancers.
TPY Capital is a Tel Aviv based early state VC, investing in some of Israel’s most talented entrepreneurs. They are active investors who typically lead rounds in the areas we invest in, which include data and analytics, digitization and human augmentation, fintech, and frontier tech such as quantum computing.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Big Data
- Stage:Seed, Series A, Series B
- Geography: Israel, United States, France
Investor stats
- Total investments: 36
- Lead/follow: no public data
Portfolio highlights
- Tabnine — Tabnine is an AI code-completion tool that helps developers worldwide write better code faster.
- Kodem Security — Providing users with runtime intelligence to grasp the relevant application risks.
- DOT Compliance — Harness the power of the AI-powered solution built for quality and compliance in life sciences. Get a demo of Dot Compliance.
e& capital invest in the ideas and people that are making a better, alternate future for all.
Show more...Investment focus
- Industry: Video, Information Technology, Social Media
- Stage:Series A, Series B, Series C
- Geography: United Arab Emirates, India, United States
Investor stats
- Total investments: 5
- Lead/follow: no public data
Portfolio highlights
- Alma Health — Alma Health is a digitally-native chronic illness management platform serving an addressable market of 20m patients in GCC. Through its cloud pharmacy and virtual doctor consultations, Alma Health is translating patient behavior and insights into personalized services and products like digital treatments and at home monitoring systems. Alma Healthis based in Hub71-Abu Dhabi.
- Clockwork Systems — 100% Software based solution to speed AI Jobs, eliminate Link/NIC failures and boost GPU utilization. Clockwork.io is built on breakthrough technology developed at Stanford University.
- MaxByte Technologies — Transform your industry with Industry X.0, the digital revolution driving innovation and efficiency. Unlocking the potential of manufacturing
Pfizer provides access to safe and effective and affordable medicines and health care services. They have a portfolio of products and medicines that support wellness and prevention, as well as treatment and cures for diseases across a broad range of therapeutic areas; and they have an industry-leading pipeline of promising new products that havethe potential to challenge some of the most feared diseases of their time, like Alzheimer's disease and cancer.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Post-IPO Equity, Series A, Seed
- Geography: United States, Israel, France
Investor stats
- Total investments: 53
- Lead/follow: no public data
Portfolio highlights
- CytoReason — CytoReason is a tech company developing a computational model of the human body. The company collects proprietary data from pharma companies and uses it to simulate human diseases – tissue by tissue, cell by cell. With CytoReason’s massive database and AI-led platform, pharma and biotech companies identify new opportunities, shorten trial phases,reduce development costs and increase the likelihood of approval. To date, six of the world’s top ten pharma companies use CytoReason’s technology.
- AgomAb Therapeutics — AgomAb is developing molecular therapies for the regeneration of damaged tissues. Their unique agonistic monoclonal antibody molecules (“agomAbs”) stimulate molecular and cellular repair mechanisms that have the potential to restore organ function in patients with fibrotic, inflammatory, autoimmune and degenerative diseases.
- EvolveImmune Therapeutics — EvolveImmune Therapeutics transforms the discovery and development of novel immunotherapies. By leveraging its proprietary in vivo target discovery platform, EvolveImmune is building a pipeline of novel therapeutic candidates against numerous targets that are expressed on multiple immune cell types. The company’s platform will generatefirst-in-class treatments for unmet needs in oncology and autoimmune diseases.
We are an early stage venture capital firm dedicated to partnering with inspiring entrepreneurs to build breakthrough companies
Show more...Investment focus
- Industry: Artificial Intelligence, Machine Learning, Software
- Stage:Seed, Series A, Series B
- Geography: Israel, United States
Investor stats
- Total investments: 41
- Lead/follow: no public data
Portfolio highlights
- ViewNetic — ViewNetic is an AgTech startup developing unique imaging and machine learning technologies for early, pre-propagation detection of pests and diseases in high-value crops.
- Infiniplex — Infiniplex is an Israel-based startup whose mission is to utilize routine blood testing to screen for genetic tumor biomarkers and to offer preemptive, preventive, and follow-up cancer screenings at a more accessible and affordable cost. Our goal is to identify common and rare cancer types through a standard, inexpensive blood test that could becarried out as part of routine checkups, leveraging existing laboratory equipment and know-how. We aim to include tumor genomic testing as part of people's standard blood test checkups. The company was founded in 2021 and is based in Yokne'am Illit, Israel.
- Intuition Robotics — The AI care companion robot for older adults
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!The Office of the Chief Scientist [OCS] in the Ministry of Economy is charged with execution of government policy for support of industrial R&D. The goal of the OCS is to assist in the development of technology in Israel as a means of fostering economic growth, encouraging technological innovation and entrepreneurship, leveraging Israel’sscientific potential, enhancing the knowledge base of industry in Israel, stimulating high value-added R&D and encouraging R&D collaboration both nationally and internationally. A variety of ongoing support programs developed and offered by the OCS play a major role in enabling Israel to be a key center for high tech entrepreneurship.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Hardware
- Stage:Seed
- Geography: Israel
Investor stats
- Total investments: 3
- Lead/follow: no public data
Portfolio highlights
- LapSpace — LapSpace Medical was founded in 2011. It operates within the framework of the Misgav Venture Accelerator, part of The Trendines Group. The LapSpace team combines strong business and medical experience and knowledge.
- Digma Medical — Digma Medical | DiaGone - safe, one-time, 30 minute, minimaly-invasive, GI procedure for Restoring Glycemic Control for T2DM & NASH patients | No Implant
- Immunovative Therapies — Immunovative Therapies is a biopharmaceutical company with financial support of the Israel Office of the Chief Scientist. ITL is a graduate of the Misgav Venture Accelerator, a member of the world renown Israel technological incubator program. The company was the Misgav Venture Accelerator's candidate for the prize for the outstandingincubator project of 2006, awarded by the Office of the Chief Scientist. They specialize in the development of novel immunotherapy drug products that incorporate living immune cells as the active ingredients for the treatment of cancer and infectious disease.
NextLeap Ventures offers investors the opportunity to invest in early stage, Israeli high-tech startups, selected through its unique, highly vetted process.
Show more...Investment focus
- Industry: Software, Machine Learning, Health Care
- Stage:Seed, Series A
- Geography: Israel, United States
Investor stats
- Total investments: 15
- Lead/follow: no public data
Portfolio highlights
- Carrar — A complete thermal management solution for electric vehicles dissipating heat faster and more efficiently than ever before. Thermal management for ev batteries.
- Cybord — Electronics components' quality, reliability, and highest level of traceability by leveraging visual AI and BigData
- Enzymit — Enzymit's platform technology can build molecular machines that enable never before seen chemistry aiming to solve humanity's greatest challenges
ALIVE Israel HealthTech Fund is a pioneer mid-to-late stage HealthTech fund leveraging an exclusive ecosystem.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series A, Series B
- Geography: Israel, United States
Investor stats
- Total investments: 12
- Lead/follow: no public data
Portfolio highlights
- Wisdo Health — Wisdo is an AI-powered Social Health platform harnessing the power of data and meaningful connections to improve health.
- Vessi Medical — Vessi Medical is developing an innovative, IP protected cryo spray for hollow & humid organs, a new approach in the treatment of Non Muscle Invasive Bladder Cancer (NMIBC).
- Gina Life — At Nevia bio, we are focused on women's health. Our mission is to use innovative technologies to provide early detection of diseases through vaginal secretions analysis, enabled by Nevia's Machine Learning Platform.
Trendlines Group invents, discovers, invests in, and incubates innovation-based medical and agrifood technologies. Trendlines invests principally through medical and agrifood incubators in Israel and in Singapore, its in-house innovation center, Trendlines Labs, and its Funds - the Trendlines Agrifood Fund and the Bayer Trendlines Ag InnovationFund.The company was founded in 1993 and is headquartered in Misgav, Israel.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Seed, Series A
- Geography: Israel, Singapore, United Kingdom
Investor stats
- Total investments: 58
- Lead/follow: no public data
Portfolio highlights
- Insectta — Insectta was founded in 2017 and produces materials from insects which can be applied across industries such as agrifood, pharmaceutical and electronics.
- Celleste Bio — Celleste is a business that specializes in employing cell culture techniques to produce high-value cocoa ingredients, removing the need for cocoa trees to be grown.
- ViAqua Therapeutics — ViAqua is developing the first orally administered treatment in aquaculture to stop diseases from developing and to prevent viral epidemics.
Annex Investments is a Multifaceted Hybrid Venture Single-Family Office, (Located in Abu Dhabi, United Arab Emirates), strategically blending the patient capital and long-term vision of a traditional SFO with the dynamic, high-growth strategies of a venture firm. We actively build businesses, forge strategic partnerships, and shape the future ofthe MENA business landscape. Our integrated approach is built upon four core pillars: Venture Capital, Joint Ventures/Strategic Partnerships, a proprietary Venture Studio and comprehensive Market Entry & Advisory services
Show more...Investment focus
- Industry: Information Technology, Software, Artificial Intelligence
- Stage:Seed, Pre-Seed
- Geography: United Arab Emirates, Saudi Arabia, United States
Investor stats
- Total investments: 10
- Lead/follow: no public data
Portfolio highlights
- Myne — Myne offers a comprehensive platform for tracking, growing, and protecting assets. The platform integrates seamlessly with various financial tools to provide users with a holistic view of their wealth. Key features include net worth tracking, budgeting, investing, and estate planning. Myne ensures data security with multiple layers of encryption,making it a secure choice for managing financial well-being.
- Keyper — Keyper simplifies real estate management for property owners, tenants, and partners. Manage portfolios, get market insights, apply for rent with flexible payment options, and explore partnership opportunities to earn passive income. Join Keyper today!
- ClearGrid — Revolutionize your debt recovery with AI and advanced analytics. Our platform delivers faster, more personalized collections that benefit both your business and your customers.
Sente is a Chicago-based startup investment and innovation platform. Sente searches the world for the most high-potential startups and helps them scale through unprecedented guidance, support, and connections.
Show more...Investment focus
- Industry: Artificial Intelligence, Machine Learning, Software
- Stage:Pre-Seed, Convertible Note, Seed
- Geography: United States, Turkey, Israel
Investor stats
- Total investments: 38
- Lead/follow: no public data
Portfolio highlights
- Kfobix — Kfobix is a renewable energy company that provides solutions for power grids and green energy production sustainable.
- M-Based — M-Based develops next-generation biomaterials using mushroom, redefining sustainability in design and materials.
- Kybele's Garden — Kybele's Garden focus on algae-based bioponics and algae fermentation methods. Their differentiation strategy boosts harvest yield, source efficiency, and functional content, while improving sensory attributes and shelf life. These technologies can be used in agrifood and skin care, and integrated into existing producers' systems.
The Land of Milk and Honey is an abundant location where life is simple and devoid of need. Both in brand-new real estate development projects and while professionally restoring and renovating houses, Milk and Honey Investments LLC aims to create distinctive spaces of abundance and healthy living.
Show more...Investment focus
- Industry: Life Science, Organic Food, Biotechnology
- Stage:Series A
- Geography: Israel
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- BioBetter — BioBetter is a foodtech company that develops plant-based platforms for the production of complex growth factors used in cultivated meat. The company was founded in 2015 and is headquartered in Israel.
Khosla Ventures is a venture capital firm that invests in early- to late-stage companies across sectors like AI, healthcare, sustainability, and consumer technology. It manages multiple funds, focusing on startups with innovative technologies or business models. The firm primarily targets sectors like AI, climate tech, digital health, and medtech,offering strategic support to help build long-lasting companies.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Series A, Series B, Seed
- Geography: United States, India, United Kingdom
Investor stats
- Total investments: 981
- Lead/follow: no public data
Portfolio highlights
- Periodic Labs — Periodic Labs develops artificial intelligence systems that simulate and predict the properties of materials using machine learning. The company applies computational models to support the discovery and design of materials used in sectors such as energy, electronics, and infrastructure. It builds tools that aim to reduce the time and costassociated with traditional research and development processes. Periodic Labs uses AI to analyze large-scale scientific data and collaborates with academic and industry partners to support material science research.
- Vectra AI — Vectra is the world leader in AI threat detection and response. The Cognito platform uses AI to detect attackers in real time and perform conclusive investigations.
- Point One Navigation — Precise Positioning for the next generation of transportation. 10cm accuracy everywhere.
GoodPaper Ventures is a venture capital company that offers private equity and investment management services.
Show more...Investment focus
- Industry: Legal, Legal Tech, E-Signature
- Stage:Series A
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- OneNotary — Looking for a reliable and convenient on-demand online notary service? OneNotary platform offers fully legal and secure notarization services in all 50 states.
- Foresee Genomics — Foresee Genomics brings high-precision NGS to every lab with fast, affordable diagnostics that advance personalized care and unlock growth.
Based out of Dubai, Knuru pursues equity and credit opportunities in fintech and marketplaces across the GCC, Africa and Southern Europe. The management is led by a team of investors and entrepreneurs bringing to venture capital extensive cross-asset class experience dedicated to supporting high growth businesses.
Show more...Investment focus
- Industry: E-Commerce, Information Technology, Financial Services
- Stage:Series A, Series C
- Geography: United Arab Emirates, Spain, Kenya
Investor stats
- Total investments: 10
- Lead/follow: no public data
Portfolio highlights
- Savana — Electronic Health Records reuse, with Clinical Natural Language Processing.
- Alma Health — Alma Health is a digitally-native chronic illness management platform serving an addressable market of 20m patients in GCC. Through its cloud pharmacy and virtual doctor consultations, Alma Health is translating patient behavior and insights into personalized services and products like digital treatments and at home monitoring systems. Alma Healthis based in Hub71-Abu Dhabi.
- The Giving Movement — Sustainable Activewear & Streetwear Clothing | Made in UAE | $4 per item donated to charity | Gym Clothing & Workout Clothes
FAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Life Science VC Funds in Middle East investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 48,091 VC funds investing in Middle East Life Science startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!